← Back to screener

MBX Biosciences, Inc. MBX

Rank #1403 · Nasdaq · $2.7B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
48.9
P/E
-42.9
P/B
-36.70
ROE
85.4%
Op. Margin
–%
Debt Ratio
-15%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -42.9x, P/B -36.70x. Ranks in the top 85% of the universe.

Profitability ★★★★★
Excellent

ROE 85.4%. Ranks in the top 5% of the universe.

Safety ★★★★★
Excellent

Debt ratio -15%. Ranks in the top 7% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2024–$-0.0B$-0.0B$-0.0B–-10
2025–$-0.1B$-0.1B$-0.1B–-15

← See the full screener